University of Missouri School of Medicine MU Health School of Medicine
Endo-gardner_d

David Gardner, MD

Associate Professor of Medicine

Clinical Profile



Clinical and Research Interests

Diabetes, Lipid Disorders, Thyroid Disorders

Contact Information

E-mail: GardnerDW@health.missouri.edu
Division: Endocrinology
Office Phone: (573) 882-3818
Office Address: DC043.00, 1 Hospital Drive
Columbia, MO

Appointments

  • 1983-present: Associate Professor of Clinical Medicine, Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine
  • 1999-present: Director, Cosmopolitan International Diabetes and Endocrinology Center
  • 2005-2008: Director, Fellowship Program, Division of Endocrinology, Diabetes and Metabolism
  • 1999-2003: Interim Director, Division of Endocrinology, Diabetes and Metabolism
  • 1997-2000: Consulting Physician, HealthSouth Rusk Rehabilitation Center
  • 1996-2000: Director, Bariatrics "Health Image" Clinic
  • 1993-2000: Director, Mid-Missouri Lipid Treatment and Education Center
  • 1977-1997: Staff physician, Harry S. Truman VA Hospital
  • 1977-1983: Assistant Professor of Clinical Medicine, Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine

Board Certifications

  • 1977: American Board of Internal Medicine, Subspecialty, Endocrinology, Diabetes and Metabolism
  • 1974: American Board of Internal Medicine

Fellowships

  • 1974-1976: Fellowship in Endocrinology, Diabetes and Metabolism, University of Missouri

Hospital/Clinic/University Committee Services

  • Department of Internal Medicine Clinical Affairs Committee, 2010-present
  • Deparment of Internal Medicine Promotion & Tenure Committee, 2010-present
  • Chairman, Committee on Tele-Education, V.A. Hospital, 1995-2000
  • Electronic Health Care Committee - University of Missouri, 1995-2003
  • Department of Medicine M4 Curriculum 1977-78
  • Department of Medicine Continuing Medical Education
  • Department of Medicine Volunteer Faculty
  • Discharge Planning Committee - V.A. Hospital - Chairman
  • Medical Records Committee - V.A. Hospital
  • Electronic Medical Records Committee - V.A. Hospital
  • Ancillary Testing Committee - V.A. Hospital
  • Library Advisory Board - V.A. Hospital
  • Student Promotions University of Missouri School of Medicine
  • Admissions Committee University of Missouri School of Medicine

Medical School

  • 1967-1971: MD, University of Missouri

Residency

  • 1971-1972: Internship in Internal Medicine, St. Louis University Group Hospitals
  • 1972-1974: Residency in Internal Medicine, St. Louis University Group Hospitals

Honors & Awards

  • 2008: Quality Service Excellence Hero, University Hospital
  • 2002: Certificate of Excellence for outstanding endocrine lectures, PBL series, University of Missouri School of Medicine (voted by medical students)
  • 2002: Service Award, Medical Student Association, University of Missouri
  • 2002: Excellence in Education: Clinical Faculty Award, Medical Student Association, University of Missouri
  • 2002: Faculty Excellence in Teaching Award, University of Missouri School of Medicine
  • 2001: Paul C.J. Sun Distinguished Faculty Award for continuing commitment to student education, University of Missouri School of Medicine
  • 2000: Outstanding Service for Excellence in Education Pre-Clinical Faculty, Medical Student Affairs Council, University of Missouri School of Medicine

Professional Societies

  • American College of Physicians
  • American Association of Medical Systems and Informatics
  • The Endocrine Society
  • American Diabetes Association
  • American College of Endocrinology, Fellow

Ongoing Research

  • 04/15/04 – 06/01/10: Proposal 0004294 – "The ORIGIN Trial: Outcome Reduction With Initial Glargine Intervention – A Multicenter, multinational, Randomized 2x2 Factorial Design Study to Evaluate the Effects of LANTUS (Insulin Glargine) Versus Standard Care, and of Omega-3 Fatty Acids Versus Placebo, in Reducting Cardiovascular Morbidity and Mortality in High Risk People with Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT) or Early Type 2 Diabetes Mellitus"

Refereed Papers

  • Krause-Buckner W, Gardner DW. Optic nerve hypoplasia, absent septum pellucidum and hypopituitarism. Am Journal of Ophthalmology 1980;89:113-20.
  • Johnson ER, Gardner DW. Familial occurrence of non-medullary thyroid carcinoma. Missouri Medicine 1981;Oct:647-49.
  • Sorkin MI, Nolph KD, Arfania D, Gardner DW. Case report: continuous ambulatory peritoneal dialysis for the treatment of hypercalcemia. Dialysis and Transplantation 1981;10:Nov:928-32.
  • Hoffman RW, Gardner DW, Mitchell FL. Intrathoracic and multiple abdominal pheochromocytomas in Von Hippel-Lindau disease. Archives of Int Med 1982;142:1962-64.
  • Gardner DW, Klachko DM. Development of a diabetic patient registry on a microcomputer. In: Levy, AH, Williams, BT, eds. American Association Medical Systems Informatics Congress. Bethesda, Maryland: American Association Medical Systems and Informatics, 1985:286-88.
  • Levy, WJ, Gardner DW, Mosely J, Dix J, Gaede SE. Unusual problems for the physician in managing a hospital patient who received a deliberate insulin overdose. Neurosurgery 1985;17:992-996.
  • Anast C, Gardner DW. Elevated circulating immunoreactive calcitonin in the magnesium deficient rat. Endocrinology 1985;116:2232-35.
  • Gardner DW, Klachko DM. A microcomputer based diabetic patient registry for patient management and clinical research. Proceedings Ninth Annual Symposium on Computer Applications in Medical Care, Nov 10-13, 1985.
  • Helikson MA, Havey AD, Zerwekh JE, Breslau NA, Gardner DW. Plasma-Cell Granuloma Producing Calcitriol and Hypercalcemia. Annals of Int. Med. 1986;105:379-383.
  • Sylvester JM, Gardner DW. A natural language interpreter for reading insulin orders. Proceedings American Association Medical Systems and Informatics Congress 1987:283-285.
  • Klachko DM, Wright DL, Gardner DW. Effect of a microcomputer-based registry on adult immunizations. J of Fam Pract 1989, 29:169-172.
  • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM, 1993;329:977-986 and related papers.
  • The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes control and complications trial. The J of Peds, 125:177-188, 1994.
  • The Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Ophthalmology, 102:647-661, 1994.
  • Balas EA, Gardner D, Handy O, Li ZR, Mitchell JA. Multipurpose practice guideline modules for clinical decision analysis and quality improvement. Medinfo (submitted).
  • The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophth, 113:36-51, 1995.
  • The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. Kidney Int'l, 47:1703-1720, 1995.
  • The Diabetes Control and Complications Trial Research Group. Implementation of treatment protocols in the diabetes control and complications trial. Diab Care, 18:361-376, 1995.
  • The Diabetes Control and Complications Trial Research Group. A comparison of the study populations in the diabetes control and complications trial and the Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med, 155:745-754, 1995.
  • The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Annals of Int Med, 122:561-568, 1995.
  • The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. The Amer J of Card, 75:894-903, 1995.
  • The Etiology of Obesity. Missouri Medicine, 100:242-247, 2003.

Invited Papers

  • Anast CS, Gardner DW. Primary hypomagnesemia. In: Bergsma D, ed. Birth defects-atlas and compendium. 2nd ed. Baltimore: Wilkins and Wilkins Co, 1978:566.
  • Anast CS, Gardner DW. X-linked infantile hypoparathyroidism. In: Bergsma D, ed. Birth defects-atlas and compendium. 2nd ed. Baltimore: Wilkins and Wilkins Co, 1978:551.
  • Gardner DW, Anast CS. Neonatal familial hyperparathyroidism. In: Bergsma D, ed. Birth defects-atlas and compendium. 2nd ed. Baltimore: Wilkins and Wilkins Co, 1978:551.
  • Gardner DW, Anast CS. Vitamin D-dependent rickets. In: Bergsma D, ed. Birth defects-atlas and compendium. 2nd ed. Baltimore: Wilkins and Wilkins Co, 1978:942.

Review Articles, books, or book chapters

  • Anast CS, Gardner DW. Disorders of magnesium metabolism. In: Bronner F, Coburn J, eds. Disorders of mineral metabolism. New York: Academic Press, Inc., 1981;3:424-82.
  • Gardner D. Lipid Disorders in Cardiovascular Diseases in Women, edited by K Dellsperger, H. Winn. CRC Press LLC, London, England. June 2006.
  • Gosavi, A., Flaker, G. and Gardner, D. Lipid Management Reduces Cardiovascular Complications in Individuals With Diabetes and Prediabetes. Preventive Cardiology, Spring 2006.

Abstracts

  • Gardner DW, Anast CS. Elevated circulating immunoreactive calcitonin (iCT) in magnesium-deficient normocalcemic rat. Endocrinology, 1978;102:143.
  • Gardner DW, Langelutting SG, Anast CS. Effects of magnesium (Mg) deficiency on circulating immunoreactive calcitonin (iCT) levels. Pediatric Research, 1979;13(317):378.
  • Schrage J, Belden J, Rosen R, Gardner D, Burns T. Lipoatrophic diabetes (LAD) associated with colonic polyposis. Diabetes, 1979 Suppl; 28:436.
  • Schrage J, Belden J, Rosen R, Gardner D, Burns T. Lipoatrophic diabetes: insulin resistance, impaired lipolysis and associated colonic polyposis. Clinical Research, 1979;27, Oct:660A.
  • Klachko DM, Gardner DW. A microcomputer based diabetic patient registry for patient management and clinical research. The XII Congress of the International Diabetics Federation. Madrid, Spain, September 23-28, 1985. (Accepted for publication)
  • Gardner DW, Klachko DM. Improved health maintenance in a diabetes clinic using a computerized registry. American Diabetes Association 46th Annual Meeting, June 21-24, 1986.
  • Klachko DM, Gardner DW. Microcomputer-aided tracking of hypertension in a diabetes center. National Conference on High Blood Pressure Control, Las Vegas, Nevada, April 24-26, 1987.
  • Gardner DW, Klachko DM, Burns TW. Computer program using Windows in diabetes mellitus patient care. Central Society for Clinical Research, Chicago, IL, November 3-5, 1993.
  • Gardner DW, Griffing GT, Hamdy O. Triple therapy of metformin, sulfonylurea, and insulin in type II diabetic patients. Central Society for Clinical Research, Chicago, IL, September 29, 1995.
  • Gardner DW, Ho H. Autoimmune thyroiditis after thymectomy: Causal or Coincidence? A case report and review of literature. 1997
Printer Friendly Secure Secure        
Follow us on Twitter!   Facebook   YouTube Videos   Instagram   Pinterest  
Website created and maintained by the Office of Communications. Contact the MU School of Medicine.
Revised: October 04, 2013 - Copyright © 2014 - Curators of the University of Missouri. All rights reserved. DMCA and
other copyright information. An equal opportunity/access/affirmative action/pro-disabled and veteran employer.